Nuomao Medtech

Nuomao Medtech is a clinical-stage medical device company based in Suzhou, China, specializing in the development of innovative interventional solutions for structural heart disease. The company's primary focus is on transcatheter valve replacement and repair technologies, including systems for aortic, mitral, and tricuspid valves. Nuomao Medtech utilizes proprietary "dry valve" technology and advanced delivery systems to provide minimally invasive alternatives to traditional cardiac surgery. Backed by leading investors such as Sequoia China and Matrix Partners China, the company is advancing its pipeline through clinical trials to address significant unmet needs in the cardiovascular market.